Randomized, placebo-controlled trial of lisofylline for early treatment of acute lung injury and acute respiratory distress syndrome
ARDS Clinical Trials Network… - Critical care …, 2002 - journals.lww.com
ARDS Clinical Trials Network, National Institutes of Health
Critical care medicine, 2002•journals.lww.comCritical Care Medicine SCCM Pediatric Critical Care Medicine Critical Care Explorations Log
in or Register Subscribe to journalSubscribe Get new issue alertsGet alerts Secondary Logo
Journal Logo Advanced Search Toggle navigation Subscribe Register Login Articles & Issues
Latest Articles Collections Podcasts For Authors Journal Info Become a Member Advanced
Search January 2002 - Volume 30 - Issue 1 Next Article FEATURE ARTICLES Randomized,
placebo-controlled trial of lisofylline for early treatment of acute lung injury and acute …
in or Register Subscribe to journalSubscribe Get new issue alertsGet alerts Secondary Logo
Journal Logo Advanced Search Toggle navigation Subscribe Register Login Articles & Issues
Latest Articles Collections Podcasts For Authors Journal Info Become a Member Advanced
Search January 2002 - Volume 30 - Issue 1 Next Article FEATURE ARTICLES Randomized,
placebo-controlled trial of lisofylline for early treatment of acute lung injury and acute …
Abstract
Objective
To determine whether the administration of lisofylline (1-[5R-hydroxyhexyl]-3, 7-dimethylxanthine) would decrease mortality in patients with acute lung injury (ALI) or acute respiratory distress syndrome (ARDS).
Design
Lippincott Williams & Wilkins